Infectious Insights
Analysis reveals new insights into global surge of Strep A infections
New analysis has revealed more about the origins of the main bacterial strain involved in an increase in lethal cases.
Analysis reveals new insights into global surge of Strep A infections
New analysis has revealed more about the origins of the main bacterial strain involved in an increase in lethal cases.
Imperial-led global human challenge consortium kick off ambitious 5-year project
On 17-18 April, an international group of researchers specialising in human challenge studies convened at Imperial College London.
Long COVID leaves telltale traces in the blood
People with long COVID have distinct patterns of inflammation detectable in the blood, which could potentially be targeted with immune therapies.
5
Feature
Eight things we learned about commercialising medical research at AYCI 2024
We learnt why you should channel Mary Somerville, how timing can make or break a startup, and other lessons from experts at All You Can Innovate 2024.
Global human challenge consortium to push for next generation of vaccines
An international group of researchers specialising in human challenge studies is embarking on a project to develop advanced virus-blocking vaccines.
Impact of artificial intelligence on AMR: Common themes and challenges
Researchers gather to explore visions, themes & challenges around the use of Artificial Intelligence (AI) to tackle antimicrobial resistance (AMR).
Global research network to combat deadly Strep A infections
Imperial and US scientists are spearheading a multi-institution network to research bacterial cause of sepsis and heart damage in children.
T cells may provide more durable protection against Omicron than antibodies
New review suggests T cells are more robust against ‘Omicron breakthroughs’ than antibodies, offering fresh insights for COVID-19 vaccine development.
Morphine treatment and cheating sparrows: News from Imperial
Here’s a batch of fresh news and announcements from across Imperial.
Immunosuppressing medicine can be interrupted to boost COVID-19 vaccine response
Interrupting treatment of immunosuppressing medicines for two weeks can significantly improve antibody immunity provided by COVID-19 booster vaccines.